From: Healthy lifestyle, DNA methylation age acceleration, and incident risk of coronary heart disease
 | Q1 | Q2 | Q3 | Q4 | per SD increase | P for trend |
---|---|---|---|---|---|---|
Whole cohort | ||||||
 No. of cases/controls | 100/145 | 118/127 | 129/116 | 144/101 | 491/489 |  |
 Multivariable adjusted* | 1.00 | 1.37 (0.90, 2.08) | 1.72 (1.12, 2.62) | 2.02 (1.32, 3.11) | 1.36 (1.15, 1.61) |  < 0.001 |
 + cell type proportion†| 1.00 | 1.38 (0.89, 2.14) | 1.68 (1.08, 2.62) | 1.84 (1.17, 2.89) | 1.30 (1.09, 1.56) | 0.003 |
 + baseline cardiometabolic risk factor** | 1.00 | 1.34 (0.85, 2.11) | 1.78 (1.13, 2.80) | 1.78 (1.12, 2.82) | 1.29 (1.08, 1.55) | 0.005 |
Men | ||||||
 No. of cases/controls | 62/78 | 62/78 | 76/68 | 77/51 | 277/275 |  |
 Multivariable adjusted* | 1.00 | 1.30 (0.73, 2.32) | 1.67 (0.95, 2.95) | 2.20 (1.22, 3.99) | 1.39 (1.10, 1.76) | 0.006 |
 + cell type proportion†| 1.00 | 1.51 (0.81, 2.80) | 1.94 (1.06, 3.54) | 2.10 (1.12, 3.96) | 1.36 (1.07, 1.74) | 0.014 |
 + baseline cardiometabolic risk factor** | 1.00 | 1.51 (0.80, 2.85) | 2.03 (1.09, 3.75) | 1.98 (1.04, 3.77) | 1.35 (1.05, 1.74) | 0.019 |
Women | ||||||
 No. of cases/controls | 38/67 | 56/49 | 53/48 | 67/50 | 214/214 |  |
 Multivariable adjusted* | 1.00 | 1.54 (0.79, 2.98) | 1.91 (0.97, 3.76) | 1.79 (0.93, 3.46) | 1.29 (1.00, 1.67) | 0.053 |
 + cell type proportion†| 1.00 | 1.38 (0.68, 2.79) | 1.49 (0.72, 3.10) | 1.47 (0.72, 3.00) | 1.18 (0.89, 1.56) | 0.247 |
 + baseline cardiometabolic risk factor** | 1.00 | 1.40 (0.67, 2.89) | 1.66 (0.77, 3.57) | 1.51 (0.72, 3.15) | 1.17 (0.87, 1.56) | 0.301 |